153 related articles for article (PubMed ID: 38436543)
1. Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma.
Parol-Kulczyk M; Durślewicz J; Blonkowska L; Wujec R; Gzil A; Piątkowska D; Ligmanowska J; Grzanka D
J Pathol Clin Res; 2024 Mar; 10(2):e12365. PubMed ID: 38436543
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Pasupuleti V; Du W; Gupta Y; Yeh IJ; Montano M; Magi-Galuzzi C; Welford SM
J Biol Chem; 2014 Feb; 289(6):3713-23. PubMed ID: 24356968
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Pei XJ; Wu TT; Li B; Tian XY; Li Z; Yang QX
Int J Med Sci; 2014; 11(1):106-15. PubMed ID: 24396292
[TBL] [Abstract][Full Text] [Related]
5. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
6. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
7. Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.
Nallandhighal S; Vince R; Karim R; Groves S; Stangl-Kremser J; Russell C; Hu K; Pham T; Cani AK; Liu CJ; Zaslavsky A; Mehra R; Cieslik M; Morgan TM; Palapattu GS; Udager AM; Salami SS
Eur Urol Oncol; 2022 Feb; 5(1):92-99. PubMed ID: 34840106
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
Funamizu N; Hu C; Lacy C; Schetter A; Zhang G; He P; Gaedcke J; Ghadimi MB; Ried T; Yfantis HG; Lee DH; Subleski J; Chan T; Weiss JM; Back TC; Yanaga K; Hanna N; Alexander HR; Maitra A; Hussain SP
Int J Cancer; 2013 Feb; 132(4):785-94. PubMed ID: 22821831
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma.
An HJ; Koh HM; Lee JS; Song DH
Medicine (Baltimore); 2020 Dec; 99(50):e23277. PubMed ID: 33327252
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study.
Parol-Kulczyk M; Gzil A; Maciejewska J; Bodnar M; Grzanka D
PLoS One; 2021; 16(6):e0253112. PubMed ID: 34157052
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Wang SS; Zheng M; Pang X; Zhang M; Yu XH; Wu JB; Gao XL; Wu JS; Yang X; Tang YJ; Tang YL; Liang XH
Mol Carcinog; 2019 Oct; 58(10):1809-1821. PubMed ID: 31219646
[TBL] [Abstract][Full Text] [Related]
12. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Koh HM; Kim DC; Kim YM; Song DH
Thorac Cancer; 2019 Dec; 10(12):2209-2217. PubMed ID: 31602798
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
Wang D; Wang R; Huang A; Fang Z; Wang K; He M; Xia JT; Li W
Oncol Rep; 2018 Nov; 40(5):2628-2636. PubMed ID: 30226561
[TBL] [Abstract][Full Text] [Related]
15. MIF promotes perineural invasion through EMT in salivary adenoid cystic carcinoma.
Zhang M; Li ZF; Wang HF; Wang SS; Yu XH; Wu JB; Pang X; Wu JS; Yang X; Tang YJ; Li L; Liang XH; Zheng M; Tang YL
Mol Carcinog; 2019 Jun; 58(6):898-912. PubMed ID: 30667094
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate biomarker
Lv Q; Xiao W; Xiong Z; Shi J; Miao D; Meng X; Yuan H; Yang H; Zhang X
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1176-1190. PubMed ID: 34856762
[No Abstract] [Full Text] [Related]
18. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
[TBL] [Abstract][Full Text] [Related]
20. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway.
He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P
Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
